Company Profile
Ginkgo Bioworks Holdings, Inc. Stock Price, News & Catalysts
- Ticker:
- DNA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States and trades in the U
Stock performance
7.21 USD (-3.99%)
Close
Last updated: August 12, 2026
609M USD
Market cap
Why the stock is moving
As of Aug 12, 2026, DNA closed down 3.99% at $7.21. No new same-company headline was identified in the current news window.
Company overview
Business overview
Ginkgo Bioworks is a synthetic biology and bioengineering platform company focused on designing organisms for industrial and life-science applications. Its business is centered on biological design services, platform partnerships, and engineering-driven value creation.
Geographic Base and Sector Classification
Ginkgo Bioworks is headquartered in the United States and trades in the U.S. market. It sits in synthetic biology and life-sciences tools.
Business Model Characteristics
The company depends on platform utilization, partner demand, and the ability to commercialize bioengineering as a service. Investors watch collaboration revenue, platform breadth, and operating discipline.
Position Within the Biotechnology Landscape
Ginkgo occupies a platform-biology niche rather than a classic therapeutics position. It matters to biotech because it sits at the enabling layer of biological design and engineering.
Future catalysts
- Ginkgo Bioworks Holdings, Inc.'s catalysts are foundry utilization, partner-funded program milestones, and any update that shows the platform is moving toward more durable economics. Investors will also watch restructuring progress and new collaboration cadence, because the stock tends to re-rate when the company proves the platform can create recurring, contract-backed revenue rather than just science ambition.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ginkgo Bioworks Holdings, Inc. (DNA)?
Ginkgo Bioworks Holdings, Inc. (DNA) most recently closed at 7.21 USD, a -3.99% move versus the previous session.
What is the market cap of Ginkgo Bioworks Holdings, Inc. (DNA)?
Ginkgo Bioworks Holdings, Inc. currently has a market capitalization of 609M USD on BioPharmSignal.
What does Ginkgo Bioworks Holdings, Inc. do?
Ginkgo Bioworks is a synthetic biology and bioengineering platform company focused on designing organisms for industrial and life-science applications. Its business is centered on biological design services, platform partnerships, and engineering-driven value creation.
On which exchange is DNA stock listed?
Ginkgo Bioworks Holdings, Inc. (DNA) is associated with NASDAQ, United States and trades in the U, Biopharma.
What is Ginkgo?
Ginkgo Bioworks Holdings, Inc.'s catalysts are foundry utilization, partner-funded program milestones, and any update that shows the platform is moving toward more durable economics.
Which conditions is Ginkgo Bioworks Holdings, Inc. targeting with Ginkgo?
Ginkgo Bioworks Holdings, Inc.'s catalysts are foundry utilization, partner-funded program milestones, and any update that shows the platform is moving toward more durable economics.
How does Ginkgo Bioworks Holdings, Inc. describe recent progress with Ginkgo?
Ginkgo Bioworks Holdings, Inc.'s catalysts are foundry utilization, partner-funded program milestones, and any update that shows the platform is moving toward more durable economics.
What is Bioworks?
Ginkgo Bioworks is a synthetic biology and bioengineering platform company focused on designing organisms for industrial and life-science applications.